Navigation Links
ThromboGenics and BioInvent Receive Technology Transfer Success Fee From Roche for the Novel Anti-Cancer Antibody, TB-403 (Anti-PIGF)
Date:1/26/2009

LEUVEN, Belgium and LUND, Sweden, January 26 /PRNewswire-FirstCall/ -- ThromboGenics NV (EURONEXT:THR) and BioInvent International AB (OMXS:BINV) announce today that they have received a technology transfer success fee of EUR5 million from Roche under the terms of their strategic alliance for the novel anti-cancer antibody, TB-403. The payment has been triggered by the successful transfer and implementation of technology and process development to Roche in relation to the ongoing clinical development of TB-403.

The TB-403 strategic alliance with Roche was signed in June 2008. Under the terms of this ongoing agreement, ThromboGenics and BioInvent received an initial upfront payment of EUR50 million, with the potential of milestone payments of up to EUR450 million following completion of a series of development and commercial milestones, as well as double digit royalties on future sales. ThromboGenics, which discovered TB-403, receives 60% and BioInvent 40% of the revenue from the deal.

Under the terms of the agreement, Roche is responsible for all development costs for TB-403, including the completion of the Phase Ib trial currently being run by BioInvent and ThromboGenics.

TB-403 (anti-PlGF) is a humanized monoclonal antibody that blocks the formation of the new blood vessels required by solid tumours to support growth. PlGF is a homologue of VEGF, and clinical evidence suggests that it plays a role in the angiogenesis of malignant tissue, and does not affect normal tissue angiogenesis.

Patrik De Haes, CEO of ThromboGenics, commented, "We are very pleased to be able to make this announcement today. The fact that we have been able to achieve the goal that has triggered this payment from Roche so quickly highlights the excellent working relationship that has developed between all parties in this important strategic alliance. We are looking forward to the results of the current Ph
'/>"/>

SOURCE ThromboGenics NV
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ThromboGenics Begins Phase III Program With Microplasmin for the Non-surgical Treatment of Back of the Eye Disease
2. ThromboGenics Announces Promising Results of MITI IV Phase II Trial in the Treatment of Acute Stroke with Microplasmin
3. ThromboGenics Completes Patient Enrolment in the Phase IIb Trial of Microplasmin in Vitrectomy (MIVI III)
4. PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications
5. Kiadis Pharma Receives Two Orphan Drug Designations for Reviroc(TM) From the FDA
6. Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial
7. PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S.
8. Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union
9. J. Craig Venter, Ph.D. Receives Double Helix Medal from Cold Spring Harbor Laboratory
10. Medarex Receives Milestone Payment for Investigational Antibody Targeting Integrin Receptors
11. Abbott Receives Complete Response Letter From FDA for Controlled-Release Hydrocodone With Acetaminophen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... , April 24, 2015  Bayer Corporation hosted its annual ... at the Bayer HealthCare US headquarters.  This is Bayer,s second ... Whippany campus, and Thursday,s event welcomed ... every day at work. Fortunately, for the kids, ... a company whose mission is "Science For A Better Life," ...
(Date:4/24/2015)... , April 24, 2015 In ... establishing employee groups around the world to access ... business hours. While there are many areas to ... must examine which best practices are necessary and ... According to research by benchmarking ...
(Date:4/24/2015)... Research and Markets ( http://www.researchandmarkets.com/research/pmbmv2/global_biobanking ) ... Market 2015-2019" report to their offering. ... at a CAGR of 7.07% over the period 2014-2019 ... into two segments: Equipment and Consumables. This report covers ... Global Biobanking market for the period 2015-2019. ...
Breaking Medicine Technology:Bayer Hosts "Take Your Child to Work Day" 2Bayer Hosts "Take Your Child to Work Day" 3Bayer Hosts "Take Your Child to Work Day" 4Work Around the Clock: Building Effective Global Capabilities 2Global Biobanking Market Report 2015-2019 - Increase in Strategic Collaborations with Beckman Coulter, Tecan & Thermo Fischer Scientific Dominating 2
... SAN DIEGO, Jan. 6, 2012  Cardium Therapeutics (NYSE Amex: ... received notice from NYSE Regulation that the Company is ... requirements of the NYSE Amex LLC (formerly the American ... In the communication from its listing exchange, Cardium ...
... 2012 Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) ... of Neurocrine Biosciences, will be presenting at the 30th Annual ... Hotel in San Francisco, California.    The corporate ... as outline the corporate plans for 2012 and beyond. ...
Cached Medicine Technology:Cardium Regains Listing Compliance With NYSE Amex 2Cardium Regains Listing Compliance With NYSE Amex 3Cardium Regains Listing Compliance With NYSE Amex 4Neurocrine Biosciences to Present at the 30th Annual J.P. Morgan Healthcare Conference 2
(Date:4/25/2015)... D.C. (PRWEB) April 25, 2015 The ... Bangladesh Worker Safety issues the following statement following the ... earthquake hit Kathmandu, Nepal, resulting in the deaths of ... massive earthquake were felt across Nepal, Bangladesh, India and ... offer my heartfelt condolences to the people of Nepal ...
(Date:4/25/2015)... Carinsurancequotesinfo.com has released a new blog ... auto insurance for flatbed trucks. , Flatbed ... other vehicles. They are mainly used for commercial purposes ... blog post explains that by comparing multiple offers, drivers ... other commercial vehicles. , It is now possible to ...
(Date:4/25/2015)... Caicos Islands, BWI (PRWEB) April 25, 2015 ... (PLS) has celebrated three months of successfully welcoming visitors ... January 5, 2015. , As part of a ... of Providenciales airport was completely redesigned to speed up ... up the process of getting out of the airport ...
(Date:4/25/2015)... 2015 The URO CENTER of NEW YORK ... chosen by the New York Academy of Medicine to receive ... the field of Urology. , Dr. Ferdinand Valentine, born in ... diseases. He was a man of rare and attractive ... Not only did he devote his life to his ...
(Date:4/25/2015)... April 25, 2015 For thirteen years, the ... income protection education event in the nation! This year, on ... Plus Group, US to take DI Day on the road ... G. Davidson, CLU, ChFC, RHU, DIA, CLTC, Chief Executive Officer ... Day reflects on the change by stating, "The first Twin ...
Breaking Medicine News(10 mins):Health News:Auto Insurance Quotes for Flatbed Trucks Available Online! 2Health News:The Tuscany on Grace Bay Celebrates Providenciales Airport Expansion With Summer Specials to Travelers! 2Health News:The 2015 Valentine Award Comes From The Heart and Goes To Famous New York Urologist 2Health News:The 2015 Valentine Award Comes From The Heart and Goes To Famous New York Urologist 3Health News:Secura Consultants Takes DI Day On The Road 2
... to reassure people that chicken is safe to eat, U.S. ... that they are free from hazardous forms of avian influenza//. ... farm before the birds are moved to processing plants, under ... trade group. Companies that account for more than 90 percent ...
... as well! The Cell Boom, a boon to communication has ... study.// ,As part of the study, ... for over 2 years. The study revealed a definite decline ... invaded work and home life. The negative impact was perceived ...
... fellow at the Women's and Children's Hospital in Adelaide, Australia ... at birth lead to severe damage of the brain tissue ... conducted in which 443 babies suffering from cerebral palsy were ... very shocking as most of the babies with cerebral palsy ...
... Gujarat Government seeks to bring down infant and mortality rates ... as 5,000 // mothers and 72,000 babies die every ... this new program named Chiranjeevi, the government aims to bring ... one. Similarly, the Health Department expects the infant mortality rate ...
... (CPI-M) and yoga guru Ramdev clashed violently on 5 January ... reported to have raised slogans against the CPI-M MP Brinda ... were laced with animal and human body parts. The police ... forcibly enter the office of the party. ...
... a rare feat, cardio-thoracic surgeons at the Government General ... in a 30-year old woman under 'spinal epidural anesthesia’. ... under general anesthesia. ,This new surgical innovation ... the patient remains conscious during the entire surgery. The ...
Cached Medicine News:Health News:U.S. Chicken Producers to Test Flocks for Bird Flu 2
... This Sarmiento style Patella-Tendon-Bearing brace is designed ... the tibia and fibula. The tibial crest ... intra medullary nailing and removal of internal ... movement of joints above and below the ...
Designed as an excellent form of primary suspension...
... Bird and Cronin, Inc. ... of Patient Footwear, Orthopedic ... Care Products. Our products ... quality and available in ...
... This lightweight orthosis is designed to ... joint while allowing unobstructed motion of ... more custom fit the splint may ... formed using a heat gun. One ...
Medicine Products: